Role of dendritic cell synthesis of complement in the allospecific T cell response

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 57-63

  Zhou, Wuding ^a   Peng, Qi ^a   Li, Ke ^a   Sacks, Steven H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allospecific T cell response; C3; Dendritic cells; Local synthesis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C9;

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; COMPLEMENT ACTIVATION; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; BONE MARROW TRANSPLANTATION; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750434877     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.012     Document Type: Review

References (74)

1. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
2. Alper C.A., Johnson A.M., Birtch A.G., and Moore F.D. Human C'3: evidence for the liver as the primary site of synthesis. Science 163 (1969) 286-288
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
4. Benard M., Gonzalez B.J., Schouft M.T., Falluel-Morel A., Vaudry D., Chan P., Vaudry H., and Fontaine M. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J. Biol. Chem. 279 (2004) 43487-43496
5. Botto M., Lissandrini D., Sorio C., and Walport M.J. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J. Immunol. 149 (1992) 1348-1355
6. Brooimans R.A., van der Ark A.A., Buurman W.A., van Es L.A., and Daha M.R. Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1. J. Immunol. 144 (1990) 3835-3840
7. Brown K.M., Kondeatis E., Vaughan R.W., Kon S.P., Farmer C.K., Taylor J.D., He X., Johnston A., Horsfield C., Janssen B.J., Gros P., Zhou W., Sacks S.H., and Sheerin N.S. Influence of donor C3 allotype on late renal-transplantation outcome. N. Engl. J. Med. 354 (2006) 2014-2023
8. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 5 (2004) 981-986
9. Castellano G., Woltman A.M., Nauta A.J., Roos A., Trouw L.A., Seelen M.A., Schena F.P., Daha M.R., and van Kooten C. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103 (2004) 3813-3820
10. Colten H.R., Ooi Y.M., and Edelson P.J. Synthesis and secretion of complement proteins by macrophages. Ann. N.Y. Acad. Sci. 332 (1979) 482-490
11. Dallman M.J. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr. Opin. Immunol. 7 (1995) 632-638
12. Dallman M.J. Immunolobiology of graft rejection. In: Thiru S., and Waldmann H. (Eds). Pathology and Immunology of Transplantation and Rejection (2001), Blackwell Science, Oxford 1-28
13. de Jong E.C., Smits H.H., and Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26 (2005) 289-307
14. Farrar C.A., Zhou W., Lin T., and Sacks S.H. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J. 20 (2006) 217-226
15. Fiebiger E., Meraner P., Weber E., Fang I.F., Stingl G., Ploegh H., and Maurer D. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 193 (2001) 881-892
16. Gutzmer R., Lisewski M., Zwirner J., Mommert S., Diesel C., Wittmann M., Kapp A., and Werfel T. Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology 111 (2004) 435-443
17. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., Haase I., Lippert U., and Zuberbier T. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 (1997) 2863-2870
18. Heeger P.S., Lalli P.N., Lin F., Valujskikh A., Liu J., Muqim N., Xu Y., and Medof M.E. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201 (2005) 1523-1530
19. Imagawa D.K., Osifchin N.E., Ramm L.E., Koga P.G., Hammer C.H., Shin H.S., and Mayer M.M. Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation. J. Immunol. 136 (1986) 4637-4643
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
21. Jagels M.A., Daffern P.J., and Hugli T.E. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 46 (2000) 209-222
22. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
23. Kawamoto S., Yalcindag A., Laouini D., Brodeur S., Bryce P., Lu B., Humbles A.A., Oettgen H., Gerard C., and Geha R.S. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J. Clin. Invest. 114 (2004) 399-407
24. Kerekes K., Prechl J., Bajtay Z., Jozsi M., and Erdei A. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol. 10 (1998) 1923-1930
25. Kopf M., Abel B., Gallimore A., Carroll M., and Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8 (2002) 373-378
26. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., and Tough D.F. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14 (2001) 461-470
27. Lechler R., Ng W.F., and Steinman R.M. Dendritic cells in transplantation-friend or foe?. Immunity 14 (2001) 357-368
28. Lechler R.I., and Batchelor J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155 (1982) 31-41
29. Legoedec J., Gasque P., Jeanne J.F., and Fontaine M. Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur. J. Immunol. 25 (1995) 3460-3466
30. Li K., Patel H., Farrar C.A., Hargreaves R.E., Sacks S.H., and Zhou W. Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. J. Am. Soc. Nephrol. 15 (2004) 2414-2422
31. Liu J., Miwa T., Hilliard B., Chen Y., Lambris J.D., Wells A.D., and Song W.C. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201 (2005) 567-577
32. Longhi M.P., Harris C.L., Morgan B.P., and Gallimore A. Holding T cells in check-a new role for complement regulators?. Trends Immunol. 27 (2006) 102-108
33. Miyazaki M., Abe K., Koji T., Furusu A., Ozono Y., Harada T., Nakane P.K., Yagame M., Endoh M., Nomoto Y., and Sakai H. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J. Am. Soc. Nephrol. 7 (1996) 2428-2433
34. Naughton M.A., Botto M., Carter M.J., Alexander G.J., Goldman J.M., and Walport M.J. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J. Immunol. 156 (1996) 3051-3056
35. Passwell J., Schreiner G.F., Nonaka M., Beuscher H.U., and Colten H.R. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J. Clin. Invest. 82 (1988) 1676-1684
36. Patel H., Smith R.A., Sacks S.H., and Zhou W. Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J. Am. Soc. Nephrol. 17 (2006) 1102-1111
37. Peng H., Takano T., Papillon J., Bijian K., Khadir A., and Cybulsky A.V. Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J. Immunol. 169 (2002) 2594-2601
38. Peng Q., Li K., Patel H., Sacks S.H., and Zhou W. Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J. Immunol. 176 (2006) 3330-3341
39. Pippin J.W., Durvasula R., Petermann A., Hiromura K., Couser W.G., and Shankland S.J. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J. Clin. Invest. 111 (2003) 877-885
40. Pratt J.R., Abe K., Miyazaki M., Zhou W., and Sacks S.H. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am. J. Pathol. 157 (2000) 825-831
41. Pratt J.R., Basheer S.A., and Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8 (2002) 582-587
42. Pratt J.R., Jones M.E., Dong J., Zhou W., Chowdhury P., Smith R.A., and Sacks S.H. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am. J. Pathol. 163 (2003) 1457-1465
43. Reca R., Mastellos D., Majka M., Marquez L., Ratajczak J., Franchini S., Glodek A., Honczarenko M., Spruce L.A., Janowska-Wieczorek A., Lambris J.D., and Ratajczak M.Z. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 101 (2003) 3784-3793
44. Reis e Sousa. Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 16 (2004) 21-25
45. Reis e Sousa, Stahl P.D., and Austyn J.M. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178 (1993) 509-519
46. Ritter U., Meissner A., Ott J., and Korner H. Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF. J. Leukoc. Biol. 74 (2003) 216-222
47. Rock K.L., Hearn A., Chen C.J., and Shi Y. Natural endogenous adjuvants. Springer Semin. Immunopathol. 26 (2005) 231-246
48. Sacks S., Zhou W., Campbell R.D., and Martin J. C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin. Exp. Immunol. 93 (1993) 411-417
49. Sacks S.H., Zhou W., Andrews P.A., and Hartley B. Endogenous complement C3 synthesis in immune complex nephritis. Lancet 342 (1993) 1273-1274
50. Sacks S.H., Zhou W., Pani A., Campbell R.D., and Martin J. Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 79 (1993) 348-354
51. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 (1994) 1109-1118
52. Schmidt J., Klempp C., Buchler M.W., and Marten A. Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo. Cancer Immunol. Immunother. 55 (2006) 31-38
53. Schraufstatter I.U., Trieu K., Sikora L., Sriramarao P., and DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J. Immunol. 169 (2002) 2102-2110
54. Sheerin N.S., Abe K., Risley P., and Sacks S.H. Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3. J. Am. Soc. Nephrol. 17 (2006) 686-696
55. Sheerin N.S., Zhou W., Adler S., and Sacks S.H. TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney Int. 51 (1997) 703-710
56. Sohn J.H., Bora P.S., Suk H.J., Molina H., Kaplan H.J., and Bora N.S. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 9 (2003) 206-212
57. Sparri R., and Reis e Sousa. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6 (2005) 163-170
58. Steinman R.M. Some interfaces of dendritic cell biology. APMIS 111 (2003) 675-697
59. Strom T.B., Roy-Chaudhury P., Manfro R., Zheng X.X., Nickerson P.W., Wood K., and Bushell A. The Th1/Th2 paradigm and the allograft response. Curr. Opin. Immunol. 8 (1996) 688-693
60. Suresh M., Molina H., Salvato M.S., Mastellos D., Lambris J.D., and Sandor M. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J. Immunol. 170 (2003) 788-794
61. Tang S., Zhou W., Sheerin N.S., Vaughan R.W., and Sacks S.H. Contribution of renal secreted complement C3 to the circulating pool in humans. J. Immunol. 162 (1999) 4336-4341
62. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben Tal O., Kutikov I., Gill O., and Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196 (2002) 1553-1561
63. Verschoor A., Brockman M.A., Gadjeva M., Knipe D.M., and Carroll M.C. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 171 (2003) 5363-5371
64. Verschoor A., Brockman M.A., Knipe D.M., and Carroll M.C. Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J. Immunol. 167 (2001) 2446-2451
65. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
66. Wan T., Zhou X., Chen G., An H., Chen T., Zhang W., Liu S., Jiang Y., Yang F., Wu Y., and Cao X. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103 (2004) 1747-1754
67. Weinmann O., Gutzmer R., Zwirner J., Wittmann M., Langer K., Lisewski M., Mommert S., Kapp A., and Werfel T. Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2. Immunology 110 (2003) 458-465
68. Welch T.R., Beischel L.S., and Witte D.P. Differential expression of complement C3 and C4 in the human kidney. J. Clin. Invest. 92 (1993) 1451-1458
69. Werfel T., Kirchhoff K., Wittmann M., Begemann G., Kapp A., Heidenreich F., Gotze O., and Zwirner J. Activated human T lymphocytes express a functional C3a receptor. J. Immunol. 165 (2000) 6599-6605
70. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V.S., Davoust J., and Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185 (1997) 317-328
71. Würzner R., Xu H., Franzke A., Schulze M., Peters J.H., and Gotze O. Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies. Immunology 74 (1991) 132-138
72. Zhao Y.X., Andoh A., Shimada M., Takaya H., Hata K., Fujiyama Y., and Bamda T. Secretion of complement components of the alternative pathway (C3 and factor B) by the human alveolar type II epithelial cell line A549. Int. J. Mol. Med. 5 (2000) 415-419
73. Zhou W., Sasaki O., Miyazaki M., Abe K., Koji T., Verroust P., Tsukasaki S., Ozono Y., Harada T., Nakane P.K., Kohno S., and Sacks S.H. Intraglomerular C3 synthesis in rats with passive Heymann nephritis. Am. J. Pathol. 151 (1997) 1249-1256
74. Zhou W., Patel H., Li K., Peng Q., Villiers M.B., and Sacks S.H. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107 (2006) 2461-2469